Information Provided By: 
Fly News Breaks for June 20, 2017
ZTS
Jun 20, 2017 | 08:57 EDT
Hilliard Lyons reinstated coverage on Zoetis with a Buy and a $77 price target. Analyst Kurt Kemper believes management will be able to grow share via diagnostics and genetics in the broader animal health market and said the company can generate double digit earnings growth.
News For ZTS From the Last 2 Days
ZTS
Apr 23, 2024 | 05:05 EDT
Barclays lowered the firm's price target on Zoetis to $230 from $260 and keeps an Overweight rating on the shares ahead of the Q1 report. The analyst expects the Q1 reports to provide continuing evidence of improvement in generics and biosimilars for the specialty pharmaceuticals group.
